AAAAAA

   
Results: 1-8 |
Results: 8
Structure-activity relationships of neuropeptide FF: role of C-terminal regions
Authors: Mazarguil, H Gouarderes, C Tafani, JAM Marcus, D Kotani, M Mollereau, C Roumy, M Zajac, JM
Citation: H. Mazarguil et al., Structure-activity relationships of neuropeptide FF: role of C-terminal regions, PEPTIDES, 22(9), 2001, pp. 1471-1478
[I-125]EYF: a new high affinity radioligand to neuropeptide FF receptors
Authors: Gouarderes, C Mollereau, C Tafani, JAM Mazarguil, H Zajac, JM
Citation: C. Gouarderes et al., [I-125]EYF: a new high affinity radioligand to neuropeptide FF receptors, PEPTIDES, 22(4), 2001, pp. 623-629
Agonist and antagonist activities on human NPFF2 receptors of the NPY ligands GR231118 and BIBP3226
Authors: Mollereau, C Gouarderes, C Dumont, Y Kotani, M Detheux, M Doods, H Parmentier, M Quirion, R Zajac, JM
Citation: C. Mollereau et al., Agonist and antagonist activities on human NPFF2 receptors of the NPY ligands GR231118 and BIBP3226, BR J PHARM, 133(1), 2001, pp. 1-4
Functional characterization of a human receptor for neuropeptide FF and related peptides
Authors: Kotani, M Mollereau, C Detheux, M Le Poul, E Brezillon, S Vakili, J Mazarguil, H Vassart, G Zajac, JM Parmentier, M
Citation: M. Kotani et al., Functional characterization of a human receptor for neuropeptide FF and related peptides, BR J PHARM, 133(1), 2001, pp. 138-144
Tissue distribution of the opioid receptor-like (ORL1) receptor
Authors: Mollereau, C Mouledous, L
Citation: C. Mollereau et L. Mouledous, Tissue distribution of the opioid receptor-like (ORL1) receptor, PEPTIDES, 21(7), 2000, pp. 907-917
Functional inactivation of the nociceptin receptor by alanine substitutionof glutamine 286 at the c terminus of transmembrane segment VI: Evidence from a site-directed mutagenesis study of the ORL1 receptor transmembrane-binding domain
Authors: Mouledous, L Topham, CM Moisand, C Mollereau, C Meunier, JC
Citation: L. Mouledous et al., Functional inactivation of the nociceptin receptor by alanine substitutionof glutamine 286 at the c terminus of transmembrane segment VI: Evidence from a site-directed mutagenesis study of the ORL1 receptor transmembrane-binding domain, MOLEC PHARM, 57(3), 2000, pp. 495-502
Distribution of the nociceptin and nocistatin precursor transcript in the mouse central nervous system
Authors: Boom, A Mollereau, C Meunier, JC Vassart, G Parmentier, M Vanderhaeghen, JJ Schiffmann, SN
Citation: A. Boom et al., Distribution of the nociceptin and nocistatin precursor transcript in the mouse central nervous system, NEUROSCIENC, 91(3), 1999, pp. 991-1007
Distinct mechanisms for activation of the opioid receptor-like 1 and kappa-opioid receptors by nociceptin and dynorphin A
Authors: Mollereau, C Mouledous, L Lapalu, S Cambois, G Moisand, C Butour, JL Meunier, JC
Citation: C. Mollereau et al., Distinct mechanisms for activation of the opioid receptor-like 1 and kappa-opioid receptors by nociceptin and dynorphin A, MOLEC PHARM, 55(2), 1999, pp. 324-331
Risultati: 1-8 |